The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

VYGR FINANCIAL STATEMENTS

Voyager Therapeutics Inc — balance sheet, income statement and cash flow trends

VYGRVoyager Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
0200 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue34.5 M $Gross Profit-35.9 M $ · -104%Operating Income-117.2 M $ · -340%Pre-tax Income-107.6 M $ · -312%Net Income to Owners-107.7 M $ · -313%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue34.5 M $-19.1%
Gross Profit-35.9 M $—
Operating Income-117.2 M $—
EBITDA-102.8 M $—
Net Income to Owners-107.7 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets197.8 M
  • Equity154.4 M $78%
  • Current Liabilities16.7 M $8%
  • Long-term Liabilities26.7 M $13%

Key Figures

YoY change
Total Assets197.8 M $-38.6%
Total Liabilities43.4 M $-44.5%
Total Equity154.4 M $-36.7%
Cash & ST Investments116.3 M $-46.0%
Total Debt32.6 M $-19.0%
Net Debt-3.2 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-100 M0100 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-150 M-100 M-50 M0-154 M $Operating113.9 M $Investing9.8 M $Financing-30.3 M $Net Change

Key Figures

YoY change
Operating Cash Flow-154 M $—
Capital Expenditures861 K $-60.4%
Free Cash Flow-154.9 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on VYGR

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.